A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
Cristina Ramo‐Tello(Hospital Universitari Germans Trias i Pujol), Olga Carmona(Hospital de Figueres), Ferràn Torres(Evidence (Italy)), Laia Grau‐López(Hospital Universitari Germans Trias i Pujol), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Eva Martínez‐Cáceres(Hospital Universitari Germans Trias i Pujol), Mar Tintoré(Vall d'Hebron Hospital Universitari), Àlex Rovira(Centre National de la Recherche Scientifique), Anna Massuet(Hospital Universitari Germans Trias i Pujol), Albert Saiz(Hospital Clínic de Barcelona), Luís Brieva(Hebron University), Pilar Giner(Hospital Universitari Germans Trias i Pujol), Carlos Nos(Universitat Autònoma de Barcelona), A Cano(Hospital de Mataró)
Cited by 75
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k